Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viekira Pak Metabolic Effects in Hepatitis C
NCT02734173Phase 4Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Jul 2015
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Viekira Pak in hepatitis C (HCV), sponsored by Ottawa Hospital Research Institute. Started Jul 2015; status: completed.
02
Drugs
Viekira Pak
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02734173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02734173.